News | Coronavirus (COVID-19) | May 20, 2020

Atrium Health and Butterfly Network Partner for Innovation in Medical Imaging During COVID-19

Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring

Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring

May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new point-of-care ultrasound (POCUS) device. Produced by Butterfly Network, Inc., the Butterfly iQ is the world’s first portable, single-probe, whole-body ultrasound device. This POCUS device features a hand-held probe that connects to a smartphone or tablet, allowing a physician to quickly and safely examine various areas of a patient’s body, whether they are in their exam room or doing a home visit. In addition to examinations, the Butterfly iQ helps clinicians with common procedures like vascular access and putting in central lines. Unlike an X-ray or CT, it does not subject the patient to radiation and reduces infection risk to hospital staff by bringing imaging to the bedside.

“For decades, the mental image of a doctor has been someone with a stethoscope around their neck. Going forward, this revolutionary portable ultrasound device may be just as critical for the medical professional,” said Rasu Shrestha, M.D., executive vice president, and chief strategy and transformation officer at Atrium Health. “The Butterfly iQ devices have already given Atrium Health greater abilities in screening and monitoring COVID-19 patients by providing an immediate and clear picture of what’s happening in a patient’s lungs. But we see its benefit going well beyond the current pandemic. Our teams are already using it to provide care for heart patients, and we anticipate this device ushering in a new era of frontline care.”

Atrium Health has deployed a large fleet of Butterfly iQ devices which have already been used to perform thousands of scans under an agreement with Butterfly Network, Inc. The devices are active at more than 30 high-priority locations, such as COVID-19 testing centers, emergency departments, intensive care units and Atrium Health’s Sanger Heart & Vascular Institute. Butterfly iQ runs on a software platform designed to simplify the ultrasound workflow and works directly within existing systems while staying secure with cloud-based security tools.

Butterfly iQ’s uniquely small size and portability enables healthcare practitioners to safely clean the device and move between patients quickly, which is not possible with other common imaging technologies such as large ultrasound machines or other scanning machines. Atrium Health and Butterfly are continuing discussions about additional applications of the technology, including integrating it into training at a future state-of-the-art school of medicine in Charlotte, North Carolina.

“Point-of-care ultrasound has played an important role in helping health systems respond to the COVID-19 pandemic around the world. We have seen it used to assess initial lung and cardiac involvement, as well as to monitor disease progression for patients isolated in urgent care facilities, quarantined in the home or even in Atrium Health’s COVID-19 Virtual Hospital,” said John Martin, M.D., Butterfly’s chief medical officer. “The value of the Butterfly iQ extends well beyond this particular pandemic. Its ability to streamline workflow and provide clinicians important tools they need to help patients, right at their fingertips, is changing the future of medical imaging forever.”

For more information: https://atriumhealth.org/

Related Coronavirus Content:

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

Cardiac Imaging Best Practices During the COVID-19 Pandemic

RSNA Publishes COVID-19 Best Practices for Radiology Departments

ASE Guidelines for the Protection of Echocardiography Providers During the COVID-19 Outbreak

New CT Scoring Criteria for Timely Diagnosis, Treatment of Coronavirus Disease

FDA Issues New Policy for Imaging Systems During COVID-19

VIDEO: COVID-19 Precautions for Cardiac Imaging —  Interview with Stephen Bloom, M.D.

A Review of Studies Cautions Against Chest CT for Coronavirus Diagnosis

New Research Finds Chest X-ray Not Reliable Diagnostic Tool for COVID-19

VIDEO: Radiology Industry Responding to COVID-19

 

University of Washington Issues Radiology Policies for COVID-19

VIDEO: Best Practices for Nuclear Cardiology During the COVID-19 Pandemic — Interview with Hicham Skali, M.D.

New Research Highlights Blood Clot Dangers of COVID-19

Survey Reveals Most Medical Practices are Now Using Telehealth Due to COVID-19

CMS Offers Recommendations on Reopening Healthcare in Areas of Low COVID-19 Cases

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Radiologists Describe Coronavirus CT Imaging Features

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

ACC COVID-19 recommendations for the cardiovascular care team

VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

The Cardiac Implications of Novel Coronavirus

 

Related Content

Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

An example of cardiac ultrasound longitudinal strain measurements on the Epsilon EchoInsight software. This can be used to assess cardiotoxicity from chemotherapy agents. 

News | Cardio-oncology | February 25, 2021
February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMC
Advanced technologies and applications such as point-of-care, pediatrics, dry-magnets, compact MRI and fusion imaging are driving global market
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in t
55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned. #COVIDvaccine #COVID19

55-year-old woman who underwent screening mammogram and ultrasound 7 days after first COVID-19 vaccination dose. Screening mammogram and US demonstrated unilateral left axillary lymph node with cortical thickness of 5 mm on ultrasound (not shown). BI-RADS category 0 was assigned. Ultrasound from diagnostic work-up performed 7 days later showed no change in lymph node size. BI-RADS 3 was assigned.

News | Breast Imaging | February 24, 2021
Detroit-based magnetic resonance imaging (MRI) technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations).
News | Magnetic Resonance Imaging (MRI) | February 24, 2021
February 24, 2021 — Detroit-based magnetic resonance...
Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer

Image courtesy of UCLA Health

News | PET-CT | February 23, 2021
February 23, 2021 — A...
Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | February 22, 2021
February 22, 2021 — According to an...
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in

Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from (f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications. Image courtesy of Professor Alessandro Olivo

News | Breast Imaging | February 22, 2021
February 22, 2021 — A new X-ray imaging scanne
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci